Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women.
暂无分享,去创建一个
Hui Chen | Richard Calderone | R. Calderone | Dongmei Li | Haihong Hu | D. Merenstein | Daniel Merenstein | Cuiwei Wang | Pilar Hamilton | Mandy Blackmon | Dongmei Li | Hui Chen | Haihong Hu | Cuiwei Wang | Pilar R. Hamilton | Mandy L. Blackmon
[1] N. Gow,et al. Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host. , 2000, Microbiology.
[2] T. Winn,et al. Oral Candida in HIV-infected heterosexuals and intravenous drug users in Thailand. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[3] J. Sobel,et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. , 2004, The New England journal of medicine.
[4] Patrick M. Gillevet,et al. Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals , 2010, PLoS pathogens.
[5] N. Chauhan,et al. The Ssk1p Response Regulator and Chk1p Histidine Kinase Mutants of Candida albicans Are Hypersensitive to Fluconazole and Voriconazole , 2007, Antimicrobial Agents and Chemotherapy.
[6] L. Kalish,et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. , 1998, Epidemiology.
[7] S. Vermund,et al. Prevalence, Incidence, and Recurrence of Oral Lesions Among HIV-Infected Patients on HAART in Alabama: A Two-Year Longitudinal Study , 2011, Southern medical journal.
[8] S. G. Chadwick,et al. Survey of Vaginal-Flora Candida Species Isolates from Women of Different Age Groups by Use of Species-Specific PCR Detection , 2008, Journal of Clinical Microbiology.
[9] N. Gow,et al. Growth kinetics and morphology of colonies of the filamentous form of Candida albicans. , 1982, Journal of general microbiology.
[10] P. Fidel,et al. Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity. , 2004, AIDS patient care and STDs.
[11] P. Fidel. Distinct protective host defenses against oral and vaginal candidiasis. , 2002, Medical mycology.
[12] J. Chmiel,et al. AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study , 2010, AIDS.
[13] J. Sobel. Treatment of vaginal Candida infections , 2002, Expert opinion on pharmacotherapy.
[14] J. Meurman. Probiotics: do they have a role in oral medicine and dentistry? , 2005, European journal of oral sciences.
[15] J. Saunus,et al. Cellular and molecular mechanisms of resistance to oral Candida albicans infections. , 2008, Frontiers in bioscience : a journal and virtual library.
[16] M. Young,et al. The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench , 2005, Clinical Diagnostic Laboratory Immunology.
[17] G. Reid,et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14 , 2009, Letters in applied microbiology.
[18] Joseph Feldman,et al. The Women's Interagency HIV Study , 1998 .
[19] D. Soll,et al. DNA fingerprinting Candida species. , 2009, Methods in molecular biology.